Stock Market Today


The company should use about half of its cash balance for the capital budget and associated expenses as production increases.

Lilis Energy (LLEX) is a small company with some large Permian well results.

acreage interest loan Permian principal production rate results stock wells


So, Ms. Whitman said she was out.

The rules were “essential and timely” to root out risky investments and sort out financial “chaos,” Mr. Guo said in a note that was posted on Fosun’s WeChat account.

chemical chief executive Dow investors merger Mr Newsletter owner plan selling


Many investment banks are eager to stock up on technology specialists who can advise Silicon Valley denizens on mergers, initial public offerings and other transformative transactions.

With its latest hire, however, the boutique investment bank Perella Weinberg Partners wants to court more traditional companies and help show how technology is set to disrupt them.

bank companies eager investment latest Mr partner Sherlund software stock


Corning's (NYSE:GLW) shares sold off about 5 percent on the day of their latest earnings announcement. With an overview of GLW's businesses in mind, we reiterate that the company has been engaged in a multi-part transformative effort to drive growth and shareholder rewards through acquisitions, its Dow Corning divestiture, capital allocation plan and new product introductions.

acquisition business earnings Glass GLW growth market optical communication profit shares


Last week we investigated nonperforming EU loans and an EU proposal to freeze accounts if a run on a bank starts. It is an important safeguard that can be accessed as last resort only.

bank contributions deposit EU fund Greece Greek loans Single Resolution SRF


Nifty Pharma index extends fall; Lupin hits 52-week low [-0.07]

Posted on July 31, 2017, 9:45 a.m. by Markets @ [source]

Shares of pharmaceutical companies continued to trade under pressure with index down more than 1% for the third straight trading sessions after firms reported a disappointing set of numbers for the quarter ended June 2017 (Q1FY18).At 2:57 pm; index, the largest loser among sectoral indices, was down 2% as compared to 0.43% rise in the Nifty 50 index. In past three trading sessions, the pharma index slipped 5.6% against 0.36% rise in the benchmark index.Sun Pharmaceutical Industries, Dr Reddy’s Laboratories, Glenmark Pharmaceuticals and were down up to 3% on the National Stock Exchange (NSE).

Dr index Pharma pharmaceutical quarter Reddy rise Rs crore Sessions trading


At least six people are reportedly injured after a car plowed into a crowd of people in the Mid-Wilshire neighbourhood in Los Angeles on July 30 afternoon, with one person in critical condition.

Angeles car crowd injured Los Mid neighbourhood plowed reportedly Wilshire


Meanwhile, the retail inflation rate is running well below RBI's target. Retail investors are worried whether the valuations would sustain at current levels.

bank BSE ended index market Nifty Rs Sensex shares trading


Guo's defense comes at a time when Beijing has stepped up oversight on outbound deals as money has flown offshore and regulators are reportedly looking into bank loans made to finance those acquisitions. But the company has been relatively unscathed thus far, and Guo is likely interested in keeping things that way.

Beijing China deals firm Fosun government Guo investment Outbound overseas


Independent analyst Kunal Bothra has buy call on Infosys with a target price of Rs 1,050.The current market price of Infosys is Rs 1,010.1.Time period given by analyst is intraday when Infosys price can reach defined target.Kunal Bothra recommended to keep stoploss at Rs 990.Infosys, incorporated in the year 1981, is a Large Cap company (having a market cap of Rs 2,29,200.62 crore) operating in Information Technology sector.Infosys key Products/Revenue Segments include Software Development Charges which contributed Rs 59,257 crore to Sales Value (99.94 per cent of Total Sales) and Software Products which contributed Rs 32 crore to Sales Value (0.05 per cent of Total Sales)for the year ending 31-Mar-2017.For the quarter ended 30-06-2017, the company has reported a Consolidated sales of Rs 17078 crore, down .25 per cent from last quarter Sales of Rs 17,120 crore and up 1.76 per cent from last year same quarter Sales of Rs 16,782 crore.Company has reported net profit after tax of Rs 3,554 crore in latest quarter. Company has BSR & Co. LLP as its auditors.

analyst Bothra cent Infosys Kunal Mr quarter Rs Rs crore sales


The scam-hit National Spot Exchange ( NSEL ) has urged markets regulator Sebi to resolve the Rs 5,600-crore payment crisis in the larger interest of investors.The payment crisis at NSEL -- part of Jignesh Shah-led FTIL group -- came to light in late 2013.Since then, multiple agencies including Sebi, the Directorate of Enforcement (ED) and the Reserve Bank of India (RBI) are probing the irregularities at the now-defunct NSEL.In a public notice, NSEL has requested the Securities and Exchange Board of India (Sebi) to resolve the market crisis. Yet, its impeccable credentials were reaffirmed when the group's exchange assets were bought by the world's most fit and proper," NSEL noted.NSEL has helped in tracking the assets of the defaulter and initiated disbursal of the recovered money, it said.NSEL was incorporated with Financial Technologies (India) Ltd, or FTIL, holding 99.98 per cent, with an objective of operating a pan-India commodities spot exchange platform for which it obtained licences under APMC Acts of various states.

crisis Exchange FTIL India market NSEL payment resolve Sebi spot


NEW YORK — Weary Republicans in Washington may be ready to move on from health care, but conservatives across the United States are warning the GOP-led Congress not to abandon its pledge to repeal the Obama-era health law — or risk a political ... Republicans try to move forward CNN Who Ate Republicans' Brains?

care Conservatives Health ready Republicans states United WASHINGTON Weary York


State Bank of India (SBI) has introduced a two-tier structure on deposits.

CLICK HERE TO CHECK SBI'S CREDIT-DEPOSIT (CD) RATIO deposits with since June 2011, as with most other banks, earned an interest of 4%.

analyst bank cost crore deposit development interest Rs SBI stock


FMCG major Godrej Consumer Products Ltd GCPL ) today reported an 8.70 per cent decline in consolidated net profit at Rs 225.17 crore for the quarter to June due to tepid sales post GST and higher expenses.The company had posted net profit of Rs 246.65 crore in April-June a year ago.Net sales during the period under review were up 3.42 per cent at Rs 2,266.69 crore as against Rs 2,191.64 crore of the corresponding quarter of the previous fiscal, the company said in a BSE filing.Total expenses during the period was at Rs 1,998.88 crore, up 6.53 per cent, as against Rs 1,876.23 crore.For the June quarter, GCPL's revenue from the domestic market grew 5.35 per cent to Rs 1,196.16 crore, from Rs 1,135.39 crore a year earlier. Indonesia delivered a weak performance with 11 per cent decline, but we expect gradual recovery in growth rates with improving macro-economic conditions," she added.Contribution from other markets was at 260.27 crore, up 2.49 per cent, from Rs 253.93 crore of the corresponding period of 2016-17.The stock was trading at Rs 1,036.40 on the BSE today, down 1.87 per cent from the previous close.

cent decline expenses GCPL June net profit quarter Rs crore sales


LONDON: Strong gains among mining stocks and an HSBC-led rally in banks lifted European shares on Monday, putting the region's equities on track to end the month unchanged on the final trading day of July.The pan-European STOXX 600 index was up 0.3 per cent by 0833 GMT, while blue chips gained 0.2 per cent. Britain's commodity-heavy FTSE 100 index was up 0.5 per cent while Germany's DAX rose 1 per cent.Financials gave a big boost to the STOXX, with banks up 0.5 per cent, led higher by a 2.8 per cent gain in HSBC , which rallied after the lender posted a forecast-beating 5 per cent rise in first half pretax profit and announced its third buyback in a year.Results also helped shares in French drugmaker Sanofi gain around 2 per cent, after it raised its 2017 outlook on the back of strong sales growth in its second quarter.As the European second quarter earnings season gathers pace, so far around 45 per cent of MSCI Europe firms have reported results, 58 per cent of which have either met or beaten analysts' expectations, according to Thomson Reuters data.This figure is slightly lower for euro zone firms, of which just over half have met or beaten expectations.

banks cent European gain HSBC index led shares STOXX strong


TOKYO: Japan's Nikkei ended slightly softer on Monday and at 6-1/2-week lows as a sell-off in index heavyweight stocks SoftBank and Fanuc offset gains in steelmakers and other companies with upbeat earnings The Nikkei fell 0.2 percent to 19,925.18 points, its lowest close since June 15. The issue will be added to the Nikkei index on Tuesday, replacing Toshiba Corp."There were both positive and negative catalysts in the market today, but thanks to strong earnings by some companies, the market's downside was supported," said Takuya Takahashi , a strategist at Daiwa Securities.Steelmakers gained sharply following solid earnings.Kobe Steel jumped 8.9 percent and Nippon Steel & Sumitomo Metal gained 3.1 percent.That helped to make the Tokyo Stock Exchange's iron and steel subindex the best performer among the TSE's 33 industry subindexes, gaining 2.2 percent.

Corp earnings gain gained index Nikkei Softbank Steel stock Tokyo


NEW DELHI: Shares of Kanani Industries (up 19.91 per cent), ICSA (India) (up 19.64 per cent), Venus Remedies (up 17.13 per cent) and Nakoda (up 16.67 per cent) zoomed up to 20 per cent on NSE in Monday's trade.Other stocks such as Sujana Metal (up 13.51 per cent), ADF Foods (up 13.44 per cent), Celestial Biolabs (up 11.74 per cent), Nicco Corporation (up 10 per cent) and MVL (up 10 per cent) surged more than 10 per cent.The domestic equity market remained positive, backed by bank, metal, IT and auto stocks.However, pharma and FMCG stocks were reeling under selling pressure.Dr. Reddy's Laboratories (down 3.23 per cent) was the top loser, taking its losing streak to a third consecutive session.The company, on Thursday, had reported a 53.21 per cent year-on-year fall in consolidated net profit at Rs 59.10 crore for the June quarter.State Bank of India (up 3.56 per cent) was trading as the top gainer after it cut savings rate.Benchmark Nifty50 index was 35 points up at 10,049, while the 30-share Sensex was 150 points up at 32,459 around 1.15 pm (IST).In the Nifty50 pack, 29 stocks were trading in green, while 22 stocks were in red.On BSE, 1,323 stocks were advancing whereas 1,199 stocks were lagging.

bank cent India metal On stocks The top trading year


Please consult with an investment professional before you invest your money. Unless your investments are FDIC insured, they may decline in value.

consult FDIC future guarantee invest investment money past performance professional